BCG and HIV reconsidered: moving the research agenda forward.
Hesseling
A C
AC
Cotton
M F
MF
Marais
B J
BJ
Gie
R P
RP
Schaaf
H S
HS
Beyers
N
N
Fine
P E M
PE
Abrams
E J
EJ
Godfrey-Faussett
P
P
Kuhn
L
L
D001500:BCG Vaccine / Q000008:administration & dosage / Q000276:immunology*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007231:Infant, Newborn; D009163:Mycobacterium bovis / Q000187:drug effects / Q000276:immunology; D014376:Tuberculosis / Q000276:immunology* / Q000517:prevention & control
D001500:BCG Vaccine